Radiation Oncology Department and Breast Center, Henri Mondor Breast Unit, University Hospital Henri Mondor, Creteil, FranceBreast neoplasms; Gynecologic cancers; Hematologic malignancies; Prostate cancer; Rare tumors; Radiation oncology
Chairman of the Department of Radiation Oncology, Head of the Henri Mondor Breast Unit, University Hospital Henri Mondor, France
Professor in Radiation Oncology, University of Paris XII
Shanghai University of Medicine & Health Sciences, Shanghai, ChinaNuclear medicine; Molecular imaging; Molecular probes; Tumor radiomics; Biomedical engineering
Chairman of the Ninth Committee of the Nuclear Medicine Society of the Chinese Medical Association
Dean of Shanghai Health Medical College
Director of Shanghai Key Laboratory of Molecular Imaging, Director of Institute of Clinical Nuclear Medicine, Dean of the School of Nuclear Medicine, Shanghai Jiao Tong University
Shandong Cancer Hospital, Jinan, ChinaChemoradiotherapy; Immunotherapy; Non-small cell lung cancer; Esophageal squamous cell carcinoma
Academician of the Chinese Academy of Engineering
Honorary President of Shandong Academy of Medical Sciences
President of Shandong Cancer Hospital
Department of Radiation Oncology, Peking University Third Hospital, Beijing, ChinaComprehensive treatment of head and neck tumors; Lung cancer; Esophageal cancer; Prostate cancer; Rectal cancer; Vertebral body tumors; Soft tissue tumors; Minimally invasive brachytherapy for metastatic cancer
Chairman of the Radiation Oncology Branch of the Chinese Medical Association, China
Director of the Department of Radiation Oncology, Peking University Third Hospital, China
President of the Lanzhou Branch of Wuwei Cancer Hospital, Gansu Province, China
Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, ChinaMulti-modal imaging technologies; SPECT/CT; PET/CT; PET/MR; Long-wheelbase PET systems; Molecular probes
Director of the Department of Nuclear Medicine, Zhongshan Hospital Affiliated with Fudan University, China
Director of the Institute of Nuclear Medicine at Fudan University, China
Deputy Director of Shanghai Institute of Imaging Medicine, China
Division of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, Geneva, SwitzerlandPET imaging; Artificial intelligence; Quantitative imaging; Nuclear medicine; Instrumentation; Medical physics
Hossein Arabi received the Ph.D. degree in medical physics from the University of Geneva, in 2016. From 2016 to 2021, he was a Postdoctoral Fellow in medical image processing and artificial intelligence with the University of Geneva, where he was a Senior Research Assistant, in 2021. He is currently a Senior Research Assistant with the Department of Nuclear Medicine, Geneva University Hospital.
Department of Radiation Therapy, the First Affiliated Hospital with Nanjing Medical University, Nanjing, ChinaClinical radiation oncology therapeutics; Radiation biology
Chief Physician (Level 2), Professor, Doctoral Supervisor
Director, Department of Radiation Oncology, Jiangsu Provincial People’s Hospital
Academic Leader, Key Discipline of Radiation Oncology, Jiangsu Provincial Health Commission
Vice Chair, 11th Committee of Radiation Oncology, Chinese Medical Association
Chair, Breast Cancer Working Group, Radiation Oncology Branch, Chinese Medical Association
Vice Chair, Esophageal Cancer Working Group, Radiation Oncology Branch, Chinese Medical Association
Vice Chair, Esophageal Cancer Working Group, Radiation Oncology Branch, Chinese Medical Doctor Association
Vice Chair, Esophageal Cancer Working Group, Radiation Oncology Branch, Chinese Anti-Cancer Association
UT Southwestern Medical Center, Dallas, United StatesRo-radiation oncology; Neurological surgery
Professor and Chair of Radiation Oncology
Professor of Neurosurgery
Effie Marie Cain Distinguished Chair in Cancer Therapy Research
National Principal Investigator of Radiation Therapy Oncology Group (RTOG) trials
Department of Medical Oncology, Affiliated Zhongshan Hospital of Dalian University, Dalian, ChinaRadiation oncology; Brachytherapy; Molecular biology oncology
President, Zhongshan Hospital Affiliated to Dalian University
Dean, Zhongshan Clinical College
Head, Leading Group for Standardized Residency Training
Chair, Expert Committee for Standardized Residency Training
Academic Leader, Key Clinical Specialty of Oncology in Liaoning Province
Director, Dalian Municipal-Level Key Discipline & Dalian Medical Soft Power Oncology Base
Department of Nuclear Medicine, Xijing Hospital, the Fourth Military Medical University, Xi’an, ChinaThyroid disease; Radionuclide therapy for bone metastases; Nuclear medicine diagnosis; SPECT; PET/CT
Director, Department of Nuclear Medicine, Xijing Hospital
Professor, Chief Physician, Doctoral Supervisor
Expert Receiving Special Government Allowance from the State Council
Fellow, American College of Nuclear Medicine (ACNM)
Chairman, Nuclear Medicine Branch, Chinese Medical Association
Vice President, Nuclear Medicine Physician Branch, Chinese Medical Doctor Association
Chairman, Shaanxi Provincial Society of Nuclear Medicine and Molecular Imaging
Department of Nuclear Medicine, Peking University Cancer Hospital, Beijing, ChinaNuclear medicine; Radiopharmaceuticals; Radio-probe; Chemoradiotherapy
Director, Department of Nuclear Medicine, Peking University Cancer Hospital
Deputy Director, Department of Nuclear Medicine, Peking University Health Science Center
Director, NMPA Key Laboratory for Radiopharmaceutical Research and Evaluation
Director, Beijing Municipal Center for Nuclear Medicine Quality Control & Improvement
Chairperson, Society of Radiopharmaceuticals, Chinese Nuclear Society
Chair-Elect, Nuclear Medicine Branch, Beijing Medical Association
Proton Therapy Center, Azienda Provinciale per i Servizi Sanitari (APSS), Trento, ItalyRadiotherapy; Proton therapy; Radiosurgery; Brain tumors; Skull base tumors
First-level Medical Director at the Proton Therapy Unit of the Provincial Health Services Authority (APSS) of Trento
Medical advisor for the treatment of brain and skull base tumors, tumors of the male genitourinary system, and the thoracic region
Coordinator for the development of the proton radiosurgery technique for brain tumors
Member of the internal working group for the development of the treatment of tumors in mobile organs (lung) and for the development of the intensity-modulated proton therapy technique
Coordinator for patient immobilization systems during proton therapy
Coordinator of the Company's Multidisciplinary Neuro-oncology Group
Holder of a Level 3A Corporate High Professionalism Appointment, "Neuro-oncology in Proton Therapy"
Department of Radiology, University of Pennsylvania, Philadelphia, United StatesComputed tomography; Imaging; Medical imaging; Neuroimaging; Neurodegenerative diseases; Magnetic resonance; Surgery; Neuroscience; Density functional theory; Neonatology
Abass Alavi is an Iranian-American physician-scientist specializing in the field of molecular imaging, most notably in the imaging modality of positron emission tomography (PET). In August 1976, he was part of the team that performed the first human PET studies of the brain and whole body using the radiotracer [18F]Fluorodeoxyglucose (FDG). Alavi holds the position of Professor of Radiology and Neurology, as well as Director of Research Education in the Department of Radiology at the University of Pennsylvania. Over a career spanning five decades, he has amassed over 2,300 publications and 60,000 citations, earning an h-index of 125 and placing his publication record in the top percentile of scientists.
Department of Physics, University of Pavia, Pavia, ItalyBNCT; Nuclear physics
Saverio Altieri played a major role in the Taormina project for the treatment by BNCT of diffuse hepatic metastases on explanted liver. He worked on the assessment of a technique for the boron concentration measurement (alpha spectrometry) and imaging (neutron autoradiography). Coordinator of Pavia University BNCT group in collaboration with national and international Institutions; main efforts devoted to the collaboration with the CNAO for the realization of an AB-BNCT facility.
Department of Medical Physics and Biomedical Engineering, University College London, London, United KingdomProton therapy; Ion beam therapy; FLASH radiotherapy; Radiotherapy physics; BNCT
Richard is Hon. Associate Professor of Proton Therapy at UCL and former Lead for Proton Therapy Physics at UCL Hospitals NHS Foundation Trust.
Richard trained as a clinical scientist at the Royal Free Hospital in London before working as a clinical radiotherapy physicist for several years in the NHS and for Cancer Care Ontario in Canada. He also worked at the Gray Laboratory Cancer Research Trust managing and using the ion microbeam facility for the study of radiation bystander effects in vitro.
Department of Health Sciences (DISSAL), University of Genoa, Genoa, ItalyNuclear medicine; Molecular imaging; Medical imaging; Radionuclide imaging and therapy; Imaging; Radioligand therapy; Prostate cancer; Clinical and preclinical functional imaging; Oncological; Cardiological and neurological applications; PET/SPECT
Head of Radiometabolic Therapy, San Martino Polyclinic Hospital
Associate Professor, University of Genoa
Department of Radiation Therapy, Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China.Breast tumors; Precise radiotherapy; Itensity-modulated radiotherapy; Stereotactic radiotherapy; TOMO
Professor and Chief Physician, Graduate Supervisor
Deputy Director of Radiation Oncology Department, Cancer Hospital, Chinese Academy of Medical Sciences
Key Member of Ministry of Education Innovation Team
Vice Chair of Youth Group, Radiation Oncology Society, Chinese Medical Association
Vice Chair of Youth Committee, Radiotherapy Professional Committee, Chinese Anti-Cancer Association
Vice Chair of Lung Cancer Group, Radiotherapy Committee, Chinese Medical Doctor Association
Council Member of CSCO
Member of NSCLC/SCLC/Radiotherapy Committees, CSCO
Committee Member of Radiation Oncology Society, Beijing Medical Association
Radiation Oncology Center, Fondazione Poliambulanza, Brescia, ItalyStereotactic body radiation therapy (SBRT); Brain radiosurgery; Innovative radiation technology (IRT); Pancreatic cancer; Liver tumors
Health Manager, Zaffiro Nord SRL, Brescia office
Radiation Oncologist, Poliambulanza Foundation Multispecialty Hospital Institute
Department of Radiation Oncology, Healthcare Global Enterprises Limited, Bangalore, IndiaHead and neck Cancer; Breast cancer; Cervical cancer; Radiation oncology; Highly conformal radiation
Dr. Ramesh S Bilimagga is a highly experienced and passionate radiation oncologist with more than 45 years of expertise in the field. He is one of the senior radiation oncologists at HCG Network. He is well-versed in highly conformal radiation therapy techniques such as IGRT, IMRT, SRS, and SBRT and is a certified CyberKnife specialist. He is also known for introducing hyperthermia treatment, along with external beam radiation therapy and has a keen interest in brachytherapy administration for cancers of the head and neck, breast, and cervix. He has contributed to chapters on Breast and Lung Monograms. He is a fellow at the International College of Surgeons. He is also a founding fellow of the Indian College of Radiation Oncology. He is a past National President of AROI (Association of Radiation of India), Indian Brachytherapy Society (IBS), and Past Vice-President of Federation of Asian Radiation Oncology's (FARO). Currently, Dr. Ramesh is the president of IAHOM (Indian Association of Hyperthermic Oncology and Medicine) and President-Elect of ISO (Indian Society of Oncology). Dr. Ramesh has been awarded the Dr. B.C Roy award from IMA, Karnataka State Branch. He has also been an orator on many occasions at various national professional organisations.
1. Institut Pluridisciplinaire Hubert Curien, Université de Strasbourg, Strasbourg, France;
2. UMR7178, CNRS, Strasbourg, FranceMolecular imaging; Positron emission tomography; Instrumentation; Image reconstruction; Preclinical studies
David Brasse received the Ph.D. degree in physics, Paris V University, Paris, France, in 1999, with a focus on PET imaging using SPECT systems. He has been the Research Director, Level 2 of CNRS, IPHC, UMR 7178, since 2012. He has authored two book chapters, more than 70 peer-reviewed articles, and two patents. His research interests include micro-dosimetry, proton therapy, PET imaging and SPECT systems, radiation therapy, and the interface between physics, biology, and medicine—preclinical instrumentation. Dr. Brasse was awarded the Scientific Excellence Award from CNRS in 2018.
Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario “A. Gemelli” IRCCS, Rome, ItalyProstate cancer (and genitourinary in general); Upper gastrointestinal malignancies (esophageal, gastric, pancreatic, liver, biliar tract cancer); Rectal cancer; Non-oncological applications of radiotherapy; Non oncological ablative radiotherapy for refractory arrhythmias; Palliative radiotherapy; Ablative radiotherapy (by SBRT); MR guided radiotherapy (MRgRT)
Department of Physics, The University of Texas at Arlington, Arlington, United StatesNanomaterials; Nanomedicine; Cancer nanotechnology
Professor of Physics, The University of Texas at Arlington.
Education:
Ph. D. in Chemistry, 1992, Peking University, Beijing, China
MS in Crystallography, 1988, Central South University, Changsha, China
BS in Mineral Chemistry, 1985, College of Earth Science, Jilin University, Changchun, China
Awards:
Distinguished young scientist award by the Chinese Academy of Sciences, 1997
Honor award for the distinguished achievement in Science & Technology by State Education Commission of China, 1995
Honor award for the achievement in Science & Technology by Peking University,1994
Research Excellent Award, University of Texas at Arlington, 2008, 2009, 2010
Serviço de Medicina Nuclear, Departamento de Radiologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro, BrazilNuclear medicine; Neuroimaging; PET imaging; Medical and biomedical image processing; Radiopharmacy; PET/CT; Radiopharmaceuticals; Nosocomial infection; Scintigraphy; Imaging; Radiolabeling; Molecular imaging; Medical imaging; Nuclear imaging; Preclinical imaging; Small animal imaging; PET Cancer imaging; Diagnostic imaging; Nuclear medicine instrumentation; Radionuclide imaging; Medical image analysis; SPECT; Radionuclide therapy; Gamma cameras; Technetium compounds; Radiolabeled in vivo studies; SPECT-CT; Radioimmunotherapy; Sentinel lymph node biopsy; Technetium; Radioisotope diagnostic techniques
Atomic Energy Cancer Hospital - NORI, Islamabad, PakistanBreast cancer; Gist gastrointestinal stromal tumor; Prostate cancer; Gliomas; Oral cavity cancer; Kaposi sarcoma cancer; Osteosarcoma pancreatic cancer; Ewing sarcoma, Retinoblastoma; Cll chronic lymphocytic leukemia; Brain metastases; Penile cancer; Paraganglioma; Chordoma; Lung cancer; Extracranial; Head and neck cancers; Gallbladder cancer; Testicular cancer
Coordinator of the International Head and Neck Scientific Group, Padua, Italypromotion of international cooperation in head and neck surgery, oncology and cancer research.
Dr. Alfio Ferlito is Formerly Director of the Department of Surgical Sciences at the University of Udine School of Medicine from 2003 to 2009 and Professor and Chairman of the ENT Clinic at the same University from 1997 to 2013. He graduated in medicine at the University of Bologna in 1968. He completed his residency programme in Otolaryngology and subsequently in pathology. He worked at the ENT Department of Padua University from 1970 to 1997. Since 2009 he is the Coordinator of the International Head Neck Scientific Group.
Dr. Alfio Ferlito received many honors and awards during his career. He served as editor, co-editor, assistant editor or reviewer for the 736 journals. He has collaborated in writing articles, editorials, commentaries, letters to the editor, special issues, book chapters and books with 665 international experts. He has edited a three-volume book entitled Cancer of the Larynx (CRC Press, Boca Raton, 1985) and three other books entitled Neoplasms of the Larynx (Churchill Livingstone, Edinburgh, 1993), etc. He is Editor of four issues of ORL Journal for Oto-Rhino-Laryngology, Head and Neck Surgery. He has been author and co-author of 657 referred publications in 70 medical journals and 54 chapters in various books. He is a fellow or a member of the many societies. He collaborated as a member of the World Health Organization’s Committee on Histological Typing of Tumors of the Upper Respiratory Tract and Ear. He is also a member of the Laryngeal Cancer Association’s Committee on the Classification of Laryngeal Cancer. He was a consultant to Yale University. He was a consultant to Yale University. He has delivered prestigious lectures all over the world. In 2006 he gave the 2nd Morrison Lecture in San Francisco and the 19th Som Lecture in New York. He has divided his professional life between clinical practice, teaching and research.
Prof. Dr. Al. Trestioreanu Oncology Discipline, Faculty of Medicine, “Carol Davila” University of Medicine and Pharmacy, Bucharest, RomaniaRadiotherapy; Brachytherapy; Head and neck cancer; Colorectal cancer; Uterine cancer
Department of Medical Sciences, RMIT University, Melbourne, AustraliaRadiotherapy physics; Dosimetry, radiobiology and imaging in radiotherapy; Applications of nanoparticles and quantum dots in radiology and radiotherapy; Radiation dose enhancement by metallic nanoparticles; Image contrast enhancement by metallic nanoaprticles
Physics Department, University of Milan, Milan, ItalyRadiation detection; Gamma spectrometry; Radiation physics; Neutron activation analysis; Radiation protection; Nuclear physics; Experimental physics; Medical physics; Dosimetry; Nuclear reactions; Radiation dosimetry; Radiation; Radioactivity
Unit of Radiation Oncology, Ospedale del Mare, Naples, ItalyUrologic oncology; Oncologic radiotherapy; Head and neck squamous cell carcinoma; Radiodiagnosis; Radiomics; Radiotherapy in NSCLC; Radiotherapy in SCLC; Radiotherapy and imaging; Precision medicine
Director of Unit of Radiation Oncology, Ospedale del Mare, Naples, Italy
Centre for Advanced Imaging, Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, AustraliaRadiotherapy; Cyclotron; PET; PET-MRI
Dr. Arif Gulzar has obtained doctorate degree in Material Science and Engineering. His research focuses on cyclotron operation for the production of novel radioisotopes such as 68Ga etc and chelator free radiolabelling of nanoparticles for cancer theragnostic.
Department of Radiation Oncology, UMass Chan Medical School and UMass Memorial Medical Center, Worcester, United StatesRadiation oncology; Thoracic oncology; Immunotherapy; SBRT
Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Shoolini University, IndiaMedicinal and pharmaceutical chemistry; Organic synthesis; Synthetic organic chemistry; Heterocyclic chemistry; Synthetic medicinal chemistry; Total synthesis; Heterocyclic compounds synthesis; Pharmaceutical chemistry; Natural product synthesis; Drug discovery; Drug synthesis; Nuclear magnetic resonance; Bioorganic chemistry; Microwave assisted organic synthesis; Click chemistry; Small molecule Drug discovery; New drug discovery; Microwave synthesis; Anticancer studies; Anti-Cancer drug design and discovery; Synthesis of medicinal compounds; Isoxazoles; Molecular recognition; Triazines; In Vitro screening; Pyrazolones; IC50; Benzimidazoles; Toxicology; Antibacterials; Docking studies; Antibacterial activity; Materials chemistry; Synthesis work; Multistep synthesis; Molecular docking; Green chemistry Technology; Asymmetric catalysis
Department of Nuclear Medicine, University Hospital of Tübingen, Tübingen, GermanyPET/CT & PET/MR (oncology, neurology, inflammation); SPECT/CT (oncology, cardiology, neurology, inflammation); Thyroid special outpatient clinic; Radioiodine therapy in thyroid disease; Peptide radioligand therapy for prostate cancer (Lu-177 PSMA); Peptide radioreceptor therapy in NET and meningiomas; Local liver therapy (SIRT); Radioligand therapy (mIBG, Zevalin)
Department of Radiation Oncology, Sichuan Cancer Hospital and Research Institute, Chengdu, Sichuan, ChinaPrecision radiation therapy for tumors; Nuclear medicine; Multidisciplinary therapies combined with chemotherapy; Molecular targeting therapy; Immunotherapy; Nutritional therapy
Department of Radiotherapy, Institute Bergonie, Bergonie, FranceElderly cancer patients; Cardiac toxicities; Cervix carcinomas; Head and neck oncology; Pharmacological biomodulation and radiation; Basic science with a particular scope in tumoral stem cells and invasion/migration
1. Cancer Research UK Scotland Institute, Garscube Estate, Glasgow, United Kingdom
2. School of Cancer Sciences, University of Glasgow; Glasgow, United KingdomMolecular Imaging; Nuclear Medicine; Oncologic Imaging; PET; Preclinical Imaging; Novel Radiotracers; Translational Imaging
Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, United StatesImage guided radiation therapy and adaptive therapy; Outcome modeling & response prediction; Application of AI/ML for image processing, analysis and automation in radiation oncology
Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, United StatesExternal beam radiation; Image-guided and intensity-modulated radiation; Prostate brachytherapy (seed implants); Stereotactic body radiation therapy; Cancers of the prostate, bladder and urinary tract, and testicular cancer
Department of Medical Surgical Sciences and Advanced Technologies “G.F. Ingrassia” – U.O. Radioterapia Oncologica, A.O.U. Policlinico “G. Rodolico—San Marco” Catania, Via Santa Sofia 78, 95123 Catania, ItalyOcular oncology; Head and neck cancer; Uveal melanoma; Radiation therapy; Proton therapy; Integrated radio-chemotherapy
Radiology and Medical Imaging Department, College of Applied Medical Sciences' Prince Sattam bin Abdulaziz University, Alkharj, Saudi ArabiaRadiation protection; Radiation safety in medical imaging; Radiobiological risks of ionising and non ionising radiation; Diagnostic reference levels in medical imaging
Department of Radiotherapy & Oncology, Hospital Kuala Lumpur, Kuala Lumpur, MalaysiaPulmonary oncology; Prostate radiation therapy; Neuro-oncology and stereotactic radiosurgery; Paediatric radiation oncology; Musculoskeletal oncology: Systemic and radiation therapy
1. Science for Life Laboratory, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden;
2. Department of Surgical Sciences, Radiology, Uppsala University, Uppsala, SwedenNuclear medicine; Radiochemistry; Radiopharmaceuticals; Positron emission tomography; Oncology; Fibrosis; Inflammation; Diabetes
Department of Radiation Oncology, RUSH Medical College, Chicago, United StatesTotal body irradiation (TBI); Total skin electron irradiation (TSEI); Bladder cancer; Brachytherapy; Head and neck tumors; Intensity-modulated radiation therapy; Intraoperative radiation therapy; Oral cancer; Prostate cancer; Radiation therapy; Sinus and skull base tumors; Soft tissue sarcoma; Testicular cancer; Tomotherapy
Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan, ChinaChest tumors; Radiation therapy; Brachytherapy; Preoperative and postoperative adjuvant therapy; Multidisciplinary comprehensive therapy; Clinical and scientific research
Department of Oncology and Gynecology, Fujian Provincial Cancer Hospital, the Affiliated Hospital of Fujian Medical University, Fuzhou, China.Gynecological tumors; Radiation therapy; Brachytherapy; Three-dimensional conformal intensity-modulated radiation therapy; Medical therapy.
Division of Radiological Sciences, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, United StatesAlzheimer’s disease; Parkinson's disease; Central nervous disorders; Postmortem biomarker validation and characterization; In vivo positron emission tomography; In vitro quantitative autoradiography
1. Department of Nuclear Medicine and Molecular Imaging, Radiological Sciences Division, Singapore General Hospital, Singapore;
2. Duke-NUS Medical School, SingaporeRadiopharmaceuticals and radiochemistry; Radiosynthesis and radiolabeling; Radioisotope production and application; Radiotracer development for nuclear imaging; Theranostics of radiopharmaceuticals; Radiation safety
Head of Radiopharmacy, Nuclear Medicine Department, University Hospital Marburg, Philipps University Marburg, Marburg, GermanyRadiopharmacy; Cancer Theragnostics Imaging and Internal Radiotherapy; Tracer development; Glutamate carboxypeptidase II; Fibroblast activation protein; Neuroendocrine Tumors
Pulmonary Department, "General Clinic Euromedica" Private Hospital, Thessaloniki, GreeceLung diseases; Gene therapy; Design, development, and therapy of novel drugs
Dr. Pavlos Zarogoulidis, M.D, Ph. D Director of Pulmonary Department, ``General Clinic Euromedica`` Private Hospital, Thessaloniki, Greece have three MS.c in ``Clinical Pharmacology``, ``Sleep Medicine`` and ``Thyroid Gland Disease and Treatment ``and my Ph. D is regarding inhaled chemotherapy for lung cancer. In my everyday practice I perform diagnosis for lung cancer with bronchoscopy, radial and convex probe endobronchial ultrasound and medical thoracoscopy.
Department of Oncology, Tengzhou Central People's Hospital, Tengzhou, ChinaTumor minimally invasive diagnosis and treatment; 3D printing template guides precise needle biopsy of pulmonary nodules; Esophageal seed stent implantation; Radioactive seed implantation; Microwave ablation; Percutaneous vertebroplasty
Department of Diagnostic Radiology, Theranostics Center of Excellence (TCE) & Clinical Imaging Research Centre (CIRC) & Nanomedicine Translational Research Program, National University of Singapore (NUS), SingaporeRadiotheranostics; Targeted radionuclide therapy (177Lu, 225Ac) in oncology; Molecular imaging; Radiochemistry; Cancer theranostics
Beijing Advanced Innovation Center for Biomedical Engineering, Beihang University, Beijing, ChinaTarget detection; Tracking and recognition technology; Multimodal image registration and fusion technology; Real scene 3D reconstruction technology; Biomedical imaging; Image processing and recognition technology
